Skip to content
10-Q

Quarterly Report

INNOVATION1 BIOTECH INC.

0001753926-25-000753

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · May 6, 2025 22.47M sh
Shares Diluted Q2 2024 · Feb 29, 2024 22.47M sh
Shares Diluted Q2 2024 · Feb 29, 2024 21.66M sh
Shares Diluted Q2 2024 · Feb 28, 2023 20.02M sh
Shares Diluted Q2 2024 · Feb 28, 2023 20.02M sh
Operating Cash Flow Q2 2024 · Feb 29, 2024 −$299.21K
Operating Cash Flow Q2 2024 · Feb 28, 2023 −$404.01K
Cash And Equivalents Q2 2024 · Feb 29, 2024 $107.53K
Cash And Equivalents Q2 2024 · Aug 31, 2023 $49.85K
Stockholders Equity Q2 2024 · Feb 29, 2024 −$3.34M
Stockholders Equity Q2 2024 · Nov 30, 2023 −$3.05M
Stockholders Equity Q2 2024 · Aug 31, 2023 −$3.43M
Stockholders Equity Q2 2024 · Feb 28, 2023 $1.48M
Stockholders Equity Q2 2024 · Nov 30, 2022 $2.08M
Stockholders Equity Q2 2024 · Aug 31, 2022 $2.85M
Current Liabilities Q2 2024 · Feb 29, 2024 $2.9M
Current Liabilities Q2 2024 · Aug 31, 2023 $3.29M
Total Liabilities Q2 2024 · Feb 29, 2024 $3.46M
Total Liabilities Q2 2024 · Aug 31, 2023 $3.51M
Current Assets Q2 2024 · Feb 29, 2024 $118.78K
Current Assets Q2 2024 · Aug 31, 2023 $72.74K
Total Assets Q2 2024 · Feb 29, 2024 $121.5K
Total Assets Q2 2024 · Aug 31, 2023 $75.99K
Eps Diluted Q2 2024 · Feb 29, 2024 −$0.02
Eps Diluted Q2 2024 · Feb 29, 2024 −$0.05
Eps Diluted Q2 2024 · Feb 28, 2023 −$0.40
Eps Diluted Q2 2024 · Feb 28, 2023 −$0.44
Eps Basic Q2 2024 · Feb 29, 2024 −$0.02
Eps Basic Q2 2024 · Feb 29, 2024 −$0.05
Eps Basic Q2 2024 · Feb 28, 2023 −$0.40
Eps Basic Q2 2024 · Feb 28, 2023 −$0.44
Sga Expense Q2 2024 · Feb 29, 2024 $9.36K
Sga Expense Q2 2024 · Feb 29, 2024 $22.81K
Sga Expense Q2 2024 · Feb 28, 2023 $93.7K
Sga Expense Q2 2024 · Feb 28, 2023 $254.71K
Net Income Q2 2024 · Feb 29, 2024 −$289.74K
Net Income Q2 2024 · Feb 29, 2024 −$544.97K
Net Income Q2 2024 · Nov 30, 2023 −$255.23K
Net Income Q2 2024 · Feb 28, 2023 −$603.39K
Net Income Q2 2024 · Feb 28, 2023 −$1.24M
Net Income Q2 2024 · Nov 30, 2022 −$631.67K
Operating Income Q2 2024 · Feb 29, 2024 $150.28K
Operating Income Q2 2024 · Feb 29, 2024 $306.12K
Operating Income restated Q2 2024 · Feb 28, 2023 $736.28K
Operating Income restated Q2 2024 · Feb 28, 2023 $1.37M
Rd Expense Q2 2024 · Feb 28, 2023 $15K